Remdesivir for the Treatment of Covid-19 — Final Report

H. Beigel, John; M Tomashek, Kay; E. Dodd, Lori; K. Mehta, Aneesh; S. Zingman, Barry; C. Kalil, André; Hohmann, Elizabeth; Y. Chu, Helen; Luetkemeyer, Annie; Kline, Susan; López de Castilla, Diego; W. Finberg, Robert; Dierberg, Kerry; F. Tapson, Victor; Hsieh, Lanny; F. Patterson, Thomas; Paredes, Roger; A Sweeney, Daniel; R. Short, William; Touloumi, Giota; Chien Lye, David; Ohmagari, Norio; Oh, Myoung‐don; M. Ruiz‐Palacios, Guillermo; Benfield, Thomas; Fätkenheuer, Gerd; G. Kortepeter, Mark; L. Atmar, Robert; Buddy Creech, C.; Lundgren, Jens; G. Babiker, Abdel; Pett, Sarah; D. Neaton, James; Burgess, Timothy; Bonnett, Tyler; Green, Michelle; Makowski, Mat; Osinusi, Anu; Nayak, Seema; Clifford Lane, H.

doi:10.1056/nejmoa2007764

Public

Remdesivir for the Treatment of Covid-19 — Final Report

Published in New England Journal of Medicine • May 22, 2020

Authors:

John H. Beigel

Kay M Tomashek

Lori E. Dodd

Abstract

BACKGROUND: Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be efficacious. METHODS: We conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults who ...

Subject

Coronavirus disease 2019 (COVID-19)

2019-20 coronavirus outbreak

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!